作者: Luisa Rossi , Rosanna Squitti , Patrizio Pasqualetti , Eliana Marchese , Emanuele Cassetta
DOI: 10.1016/S0304-3940(02)00599-2
关键词:
摘要: Copper, zinc superoxide dismutase (Cu, Zn SOD) activity was measured in red blood cells (RBC) of 32 patients affected by Alzheimer's disease (AD), eight other AD treated with the copper-chelating agent D-penicillamine, 13 first-degree relatives and 22 controls. All enrolled our study showed a higher level Cu, SOD early disease. No correlation between apolipoprotein E genotype found patients. D-penicillamine treatment for 24 weeks lowered enzyme even below control value. These results support hypothesis that RBC can be an diagnostic peripheral marker this sensor to monitor treatments drugs.